|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3265565 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16710890.1 |
| Date of filing the European patent application | 2016-03-03 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (86) | Number | PCT/US2016/020687 |
| Date | 2016-03-03 |
| (87) | Number | WO 2016/141185 |
| Date | 2016-09-09 |
| (30) | Number | Date | Country code |
| 201562128480 P | 2015-03-04 | US |
| (72) |
LU, Xiongbin, US
LIU, Yunhua, US
|
| (73) |
Board of Regents, The University of Texas System,
210 West 7th Street, Austin, TX 78701,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vėžio, turinčio hemizigotinį praradimą, gydymo būdai |
| METHODS OF TREATING CANCER HARBORING HEMIZYGOUS LOSS OF TP53 |
| Payment date | Validity (years) | Amount | |
| 2026-01-05 | 11 | 289.00 EUR |
| 2027-03-03 |